ASSERTIO HOLDINGS, INC.

Analyst Reco. Assertio Holdings, Inc.

Equities

ASRT

US04546C2052

Delayed Nasdaq Other stock markets 03:45:12 2024-05-10 pm EDT			5-day change	1st Jan Change
0.9513 ^USD	-9.40%		-6.80%	-10.28%

May. 06	Assertio Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 06	Transcript : Assertio Holdings, Inc., Q1 2024 Earnings Call, May 06, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lake Street Adjusts Assertio Therapeutics' Price Target to $3 From $4, Maintains Buy Rating	Mar. 12	MT
BWS Financial Adjusts Assertio Therapeutics' Price Target to $10 From $8, Keeps Buy Rating	23-05-10	MT
Lake Street Adjusts Assertio Therapeutics' Price Target to $9 From $8, Keeps Buy Rating	23-05-10	MT
BWS Financial Adjusts Price Target on Assertio Therapeutics to $8 From $6, Maintains Buy Rating	23-03-03	MT
Lake Street Initiates Assertio Therapeutics at Buy Rating With $7 Price Target	22-11-07	MT
BWS Financial Initiates Assertio Therapeutics at Buy, $6 Price Target	22-05-18	MT
ASSERTIO : Gabelli Upgrades Assertio Therapeutics to Buy From Hold	21-04-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW